The standard treatment for TB continues for six months. Initially, four antibiotics are prescribed. This is then reduced to two of the four antibiotics, rifampicin and isoniazid, if the person responds to treatment.
A person with multidrug-resistant TB (MDR-TB) does not respond to treatment with rifampicin and isoniazid. The treatment for MDR-TB involves other antibiotics and can last for up to 30 months.
Table 1 shows the number of reported cases of TB and MDR-TB in the South-East Asia region between 2005 and 2014, as published by the World Health Organization (WHO).
Table 1
Year |
Total number of reported cases of TB |
Total number of reported cases of MDR-TB |
2005 |
1 947 603 |
68 |
2006 |
2 104 673 |
779 |
2007 |
2 202 149 |
918 |
2008 |
2 287 803 |
1 717 |
2009 |
2 328 230 |
2 560 |
2010 |
2 332 779 |
4 263 |
2011 |
2 358 127 |
6 615 |
2012 |
2 331 455 |
14 957 |
2013 |
2 297 033 |
18 384 |
2014 |
2 580 605 |
17 386 |
Table 1 shows that between 2005 and 2014 there is an overall increase in the total number of reported cases for both TB and MDR-TB.
Describe the differences between the trend in the total number of reported cases for TB and the trend in the total number of reported cases of MDR-TB, as shown in Table 1.